Litigation Details for Wi-LAN USA, Inc. v. Apple Inc. (Fed. Cir. 2015)
✉ Email this page to a colleague
Wi-LAN USA, Inc. v. Apple Inc. (Fed. Cir. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-01-13 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | 2016-08-01 |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 10,046,056 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Wi-LAN USA, Inc. v. Apple Inc.
The biologic drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Wi-LAN USA, Inc. v. Apple Inc. (Fed. Cir. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-05-27 | 28 | transmission. (See JA77 at 10:46–56.) In the system of the ’640 Patent, the subscriber unit requests…’640 Patent and the ’040 Patent (collectively, the “Patents-in-Suit”). (JA2704–09.) The Patents-in-Suit…1507, involve four patents related to U.S. Patent No. 8,315,640, one of the patents at issue in this appeal…refers to the patent examiner’s discussion of U.S. Patent No. 6,097,733 (the “Basu Patent”) in the prosecution…when the patent examiner cited the Basu Patent to reject then- pending claim 1 of the ’640 Patent application | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
